TREMELIMUMAB

UNII:	QEN1X95CIX
Formula:
Preferred Substance Name:	TREMELIMUMAB

745013-59-6
CP-675,206
CP-675206
IMJUDO
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULFIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
PF-06753388
TICILIMUMAB
TREMELIMUMAB (GENETICAL RECOMBINATION)
TREMELIMUMAB (GENETICAL RECOMBINATION) [JAN]
TREMELIMUMAB [INN]
TREMELIMUMAB [JAN]
TREMELIMUMAB [USAN]
TREMELIMUMAB [WHO-DD]
TREMELIMUMAB-ACTL

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TREMELIMUMAB

Synonyms and Mappings

Resources